sucroferric oxyhydroxide chewable tablet

DRUG2 trials

Sponsors

University of Colorado, Denver, SIGA Technologies

Conditions

HyperphosphatemiaHypoalbuminemiaPeritoneal Dialysis ComplicationSmallpox

Phase 4

Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients

CompletedNCT04046263

University of Colorado, DenverHyperphosphatemia, Hypoalbuminemia, Peritoneal Dialysis Complication

Start: 2020-02-01End: 2021-07-31Updated: 2022-08-31

Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders

CompletedNCT04485039

SIGA TechnologiesSmallpox

Start: 2022-06-08End: 2023-04-23Updated: 2026-09-11

Related Papers

A 6-Month clinical practice pilot study of sucroferric oxyhydroxide on nutritional status in patients on peritoneal dialysis.

2022-07-092 citations